Last edition
News about "Cue Biopharma "
Cue Biopharma Prices USD 10 Million Public Offering
Cue Biopharma has priced a USD 10 million public offering, with gross proceeds expected to be approximately USD 10 million before underwriting discounts, commissions, and other offering-related expenses.
Cue Biopharma | 20/12/2025 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members